MEDA Germany Holding GmbH acts as a holding company for investments in entities engaged in the development, manufacturing, and distribution of pharmaceutical products. The company holds shares in various subsidiaries, including MEDA Pharma GmbH & Co KG and MEDA Manufacturing GmbH. It is included in the consolidated financial statements of the US-based Viatris Inc. and is subject to a profit transfer agreement with Mylan Healthcare GmbH. Operationally, the company employs an average of only one person.
Die Ausübung von Holding-Funktionen im Zusammenhang mit dem Erwerb, der Verwaltung und der Veräußerung von Beteiligungen an anderen Gesellschaften, deren Gegenstand in der Entwicklung, Herstellung oder dem Vertrieb von pharmazeutischen Produkten zur Gesundheitspflege (Health Care) oder damit zusammenhängenden Geschäften besteht. Ausgenommen sind Bankgeschäfte oder erlaubnispflichtige Finanzdienstleistungen nach dem Kreditwesengesetz.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Bad Homburg v.d.H. Local Court, HRB 9848 (as of 20 November 2026)
| Name | Type | City |
|---|---|---|
| Joachim Maus | Geschäftsführer(in) | Hanau |
Source: German Commercial Register (Handelsregister) Bad Homburg v.d.H. Local Court, HRB 9848 (as of 20 November 2026)
| Date | Event Type | Event |
|---|---|---|
| 28.06.2013 | Registered Seat Change | eingetragen als |
| 28.06.2013 | Business Address Registered | Benzstraße 1, 61352 Bad Homburg v. d. Höhe |
| 31.01.2006 | Company Name Change | MEDA Germany Holding GmbH |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 03.02.2005 | Share Capital Set | — | 1.000.000 € |
Source: German Commercial Register (Handelsregister) Bad Homburg v.d.H. Local Court, HRB 9848 (as of 20 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2022 | €0 | €0 | €185,614,279 | — |
| 2021 | ≤ €12M1 | €144,396,423 | €177,229,953 | 1 |
| 2020 | ≤ €12M1 | €0 | €187,342,111 | 2 |
| 2019 | ≤ €12M1 | €0 | €186,685,712 | 3 |
| 2018 | ≤ €12M1 | €0 | €212,878,544 | 3 |
| 2017 | ≤ €12M1 | €0 | €188,367,686 | 3 |
| 2016 | ≤ €12M1 | €36,848,333 | €181,051,710 | 3 |
| 2015 | — | €62,494,125 | €207,163,853 | — |
| 2014 | — | €37,165,328 | €183,819,786 | — |
| 2013 | — | €44,057,196 | €190,242,008 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
Source: German Company Register (Unternehmensregister) · Annual accounts
Sign in to download data
Source: German Commercial Register (Handelsregister) Bad Homburg v.d.H. Local Court, HRB 9848 (as of 20 November 2026)